Start Date
July 31, 2018
Primary Completion Date
April 30, 2023
Study Completion Date
June 30, 2023
Recombinant tissue plasminogen activator (rt-PA)
Catheter-directed thrombolysis, consisting of intrathrombus administration of rt-PA using a catheter/device.
Standard Anticoagulation Therapy
Standard anticoagulation determined by physician for a period of 3-6 months
Collaborators (1)
RTI International
OTHER
Mid America Heart Institute
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Genentech, Inc.
INDUSTRY
University of Colorado, Denver
OTHER